Small interfering RNAs in the management of human osteoporosis
G Gargano, G Asparago, F Spiezia, F Oliva… - British Medical …, 2023 - academic.oup.com
Background Osteoporosis results in reduced bone mass and consequent bone fragility.
Small interfering RNAs (siRNAs) can be used for therapeutic purposes, as molecular targets …
Small interfering RNAs (siRNAs) can be used for therapeutic purposes, as molecular targets …
Predictors of osteoporotic fracture in postmenopausal women: a meta-analysis
G Long, C Liu, T Liang, Z Zhang, Z Qin… - Journal of Orthopaedic …, 2023 - Springer
Osteoporosis affects more than 200 million women worldwide, with postmenopausal women
being particularly susceptible to this condition and its severe sequelae disproportionately …
being particularly susceptible to this condition and its severe sequelae disproportionately …
Bioinformatics and machine learning were used to validate glutamine metabolism-related genes and immunotherapy in osteoporosis patients
L Wang, C Deng, Z Wu, K Zhu, Z Yang - Journal of Orthopaedic Surgery …, 2023 - Springer
Background Osteoporosis (OP), often referred to as the “silent disease of the twenty-first
century,” poses a significant public health concern due to its severity, chronic nature, and …
century,” poses a significant public health concern due to its severity, chronic nature, and …
Association between polymorphisms of glucagon-like peptide-1 receptor gene and susceptibility to osteoporosis in Chinese postmenopausal women
X Bao, C Liu, H Liu, Y Wang, P Xue, Y Li - Journal of Orthopaedic Surgery …, 2024 - Springer
Background The influence of the glucagon-like peptide-1 receptor (GLP-1R) on bone
metabolism is well-established. However, it has been observed that single nucleotide …
metabolism is well-established. However, it has been observed that single nucleotide …
Asperuloside alleviates osteoporosis by promoting autophagy and regulating Nrf2 activation
F Huang, Y Wang, J Liu, Y Cheng, X Zhang… - Journal of Orthopaedic …, 2024 - Springer
Background Osteoporosis is a metabolic bone disease that has a common occurrence in
postmenopausal women. Asperuloside (ASP) has been reported to exert anti-inflammatory …
postmenopausal women. Asperuloside (ASP) has been reported to exert anti-inflammatory …
Comparative performance analysis of large language models: ChatGPT-3.5, ChatGPT-4 and Google Gemini in glucocorticoid-induced osteoporosis
L Tong, C Zhang, R Liu, J Yang, Z Sun - Journal of Orthopaedic Surgery …, 2024 - Springer
Backgrounds The use of large language models (LLMs) in medicine can help physicians
improve the quality and effectiveness of health care by increasing the efficiency of medical …
improve the quality and effectiveness of health care by increasing the efficiency of medical …
Pharmacological agents for bone fracture healing: talking points from recent clinical trials
F Migliorini, F Cocconi, G Vecchio… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Pharmacological strategies might influence bone healing in terms of time to
union or quality of mature bone. This expert opinion discussed the current level I evidence …
union or quality of mature bone. This expert opinion discussed the current level I evidence …
MRI-based vertebral bone quality score for the assessment of osteoporosis in patients undergoing surgery for lumbar degenerative diseases
Z Chen, F Lei, F Ye, H Yuan, S Li, D Feng - Journal of Orthopaedic Surgery …, 2023 - Springer
Purpose To explore the value of vertebral bone quality (VBQ) scores in diagnosing
osteoporosis in patients with lumbar degeneration. Methods A retrospective analysis was …
osteoporosis in patients with lumbar degeneration. Methods A retrospective analysis was …
Study on the treatment of postmenopausal osteoporosis with quercetin in Liuwei Dihuang Pill based on network pharmacology
F Zhu, W Li, L Wang, B Dai, Z Liu, H Wu… - Journal of Orthopaedic …, 2023 - Springer
Abstract Background Liuwei Dihuang Pill (LP) was verified to alleviate postmenopausal
osteoporosis (PMOP) development. Nevertheless, the major constituent of LP and the …
osteoporosis (PMOP) development. Nevertheless, the major constituent of LP and the …
Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis
G Chen, Y Chen, J Hong, J Gao, Z Xu - Journal of Orthopaedic Surgery …, 2023 - Springer
Objective Secoisolariciresinol diglucoside (SDG) is a phytoestrogen that has been reported
to improve postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. In our …
to improve postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. In our …